Free Newsletter
FDA joins Tox21 collaboration
The FDA has signed on with the Tox21 collaboration. The regulator joins the EPA, the National Institute of Environmental Health Sciences National Toxicology Program, and the National Institute of Health Chemical Genomics Center in developing models to predict how chemicals will affect human health and the environment. Release
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities


SHARE
WITH: